Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Treasury Shares: 2021-2025

  • China SXT Pharmaceuticals' Treasury Shares changed negligibly% to $2 in Q3 2025 from the same period last year, while for Sep 2025 it was $2, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2 for FY2025, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, China SXT Pharmaceuticals' Treasury Shares stood at $2, which was down 0.00% from $2 recorded in Q1 2025.
  • In the past 5 years, China SXT Pharmaceuticals' Treasury Shares registered a high of $2 during Q1 2024, and its lowest value of $0.00 during Q1 2021.
  • Its 2-year average for Treasury Shares is $2, with a median of $2 in 2025.
  • Data for China SXT Pharmaceuticals' Treasury Shares shows a peak YoY surged of 1,900.00% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows China SXT Pharmaceuticals' Treasury Shares stood at $0.00 in 2021, then soared by 1,900.00% to $0.08 in 2022, then reached $2 in 2024, then remained steady at $2 in 2025.
  • Its Treasury Shares was $2 in Q3 2025, compared to $2 in Q1 2025 and $2 in Q3 2024.